New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
08:06 EDTDPRXDipexium Pharma' begins patient enrollment for clinical trial with Locilex
Dipexium Pharmaceuticals announced it has initiated patient enrollment in the second of two pivotal Phase 3 clinical trials, known as OneStep-1 and OneStep-2, evaluating Locilex, the company's novel, broad-spectrum, topical antibiotic peptide, for the treatment of patients with mild infections of diabetic foot ulcers, or Mild DFI. According to medical literature, approximately 47% of all patients with diabetic foot infections first present at the mild stage.
News For DPRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
09:13 EDTDPRXDipexium Pharmaceuticals 1.48M share Spot Secondary priced at $12.50
The deal size was increased to 1.48M shares from 1.38M shares. Raymond James acted as sole book running manager for the offering.
June 24, 2015
16:04 EDTDPRXDipexium Pharmaceuticals files to sell common stock, no amount given
The Company intends to use the net proceeds from the offering to fund its operations and for other general corporate purposes, including, but not limited to, its internal research and development programs and the development of new programs and general working capital. Raymond James & Associates, Inc. is acting as sole book-running manager for the offering. Feltl and Company is acting as co-manager for the offering.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use